BOSTON, January 3, 2024 – VideaHealth, the leading dental artificial intelligence (AI) platform, today announced the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance for Videa Dental AI, which includes more than 30 AI algorithms and expands AI detections to cover all of the most common dental diseases.
Florian Hillen, CEO of VideaHealth, said, “This is one of the largest, most impactful FDA clearances in the history of healthcare and will elevate the patient care for the tens of millions of patients who are supported per year by VideaAI. We are now the first dental AI company offering insights for virtually every disease state in dentistry as well as enabling diagnosis of pediatric conditions. It furthers VideaHealth’s mission to support thousands of dental clinicians to provide better care to millions of patients.”
The clearance applications include periapical radiolucencies, calculus, pediatric caries detection for ages three years and older as well as many other AI models that allow for subtle detections across all ages, better workflow and time-savings. Many of these detections are the first of their kind to be issued by a regulatory agency anywhere in the world, including the first pediatric radiology AI clearance in dentistry.
Dr. Tim Quirt, Senior Vice President of Clinical Operations at Heartland Dental shared, “It is exciting that VideaHealth’s scope of AI capabilities and innovations continue to expand. We are proud to partner with VideaHealth in this fast-moving field because their vision, mission and commitment to providers are unparalleled. This is another big step forward for AI to assist supported doctors and their teams in caring for their patients’ needs, and we are excited to soon offer these expanded capabilities across our supported footprint.”
Thousands of clinicians have already selected VideaAI as their dental AI tool of choice, using it daily to provide the best possible care for millions of patients. With today’s announcement, VideaHealth is now the first dental AI company to offer insights for virtually every disease state.
See the full press release to learn more about this historic clearance.
.png)
.png)
